Levosimendan in sepsis
Open Access
- 29 May 2020
- journal article
- Published by Heighten Science Publications Corporation in Journal of Clinical Intensive Care and Medicine
- Vol. 5 (1), 020-021
- https://doi.org/10.29328/journal.jcicm.1001030
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic miceCritical Care, 2015
- The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trialsBritish Journal of Anaesthesia, 2015
- Anti-Inflammatory Profile of Levosimendan in Cecal Ligation-Induced Septic Mice and in Lipopolysaccharide-Stimulated Macrophages*Critical Care Medicine, 2015
- Septic cardiomyopathy in rat LPS-induced endotoxemia: relative contribution of cellular diastolic Ca2+ removal pathways, myofibrillar biomechanics properties and action of the cardiotonic drug levosimendanBasic Research in Cardiology, 2015
- Levosimendan in Critical Illness: A Literature ReviewJournal of Clinical Medicine Research, 2014
- The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shockJournal of Critical Care, 2012
- Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational studyCritical Care, 2011
- Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled studyCritical Care, 2010
- Effects of levosimendan in experimental acute coxsackievirus myocarditisEuropean Journal of Clinical Investigation, 2009
- Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failureThe American Journal of Cardiology, 2004